Inventory [Axis]
Biologics [Member]
Class of Stock [Axis]
Special 2022 Series A Preferred Stock [Member]
Series A Preferred Stock [Member]
Series C Preferred Stock [Member]
Common Class A [Member]
Common Class B [Member]
Product and Service [Axis]
Sales Of Supplements [Member]
Medical Procedures [Member]
Sales Of Biologics [Member]
Services [Member]
Shipping And Delivery [Member]
Supplements [Member]
Procedures [Member]
Equity Components [Axis]
Special 2022 Series A Preferred [Member]
Series A Preferred [Member]
Series C Preferred [Member]
Shares To Be Issued [Member]
Class A Common Stock [Member]
Class B Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Nonmonetary Transaction Type [Axis]
Title and Position [Axis]
Monica Sher [Member]
Richard Edwards [Member]
Kalpesh Barot [Member]
Evan Thomas [Member]
Ownership [Axis]
Cement Factory, LLC [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Product Concentration Risk [Member]
Total Revenue [Member]
Cost Of Supplements [Member]
Cost Of Revenue [Member]
Cost For Administration Of Medical Procedures [Member]
Cost Of Biologics [Member]
Total Cost Of Revenue [Member]
Biologic Products [Member]
Long-Lived Asset, Class [Axis]
Furniture and Fixtures [Member]
Machinery and Equipment [Member]
Investment, Name [Axis]
Biolete [Member]
Business Combination [Axis]
Biolete, LLC [Member]
Counterparty Name [Axis]
Cement Factory [Member]
Disposal Group Classification [Axis]
Biolete Inventory [Member]
Biolete Trademarks [Member]
Biolete Website [Member]
Long-Lived Asset, Held-for-Sale, Type [Axis]
Cement Factory Nutrition [Member]
Chief Executive Officer [Member]
Lender Name [Axis]
CEO Credit Line [Member]
Aspire Regenerative Therapy [Member]
G A I P [Member]
Award Type [Axis]
Common Stock [Member]
Sale of Stock [Axis]
Regulation A Filing [Member]
Preferred Stock [Member]
Two Officers [Member]
Adia Med Assets [Member]
Adia Labs Assets [Member]
Unallocated Corporate Assets [Member]
Segments [Axis]
Corporate Segment [Member]
Adia Med [Member]
Adia Labs [Member]
Sales Of Biologics Net Of Discounts And Refunds [Member]
Service [Member]
Lotus [Member]
Coombs [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Statement [Table]
Statement [Line Items]
ASSETS
Current Assets
Cash
Accounts receivable
Accrued interest due
Inventory
Inventory on-hand
Inventory
Prepaid expenses
Total Current Assets
Investment in non-consolidated entity
Receivable on sale of inventory asset
Loans to clinics
Deposits
Fixed assets, net of depreciation
Finance lease, net
Right of use asset - operating lease, net
Total Non Current Assets
Total Assets
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts payable
Payroll liabilities
Accrued interest – related party
Deferred revenue
Line of credit
Lease liability – current portion
Operating
Finance
Total Current Liabilities
Long-term lease liabilities, net of current portion
Operating
Finance
Total Non Current Liabilities
Total Liabilities
Stockholders' Equity (Deficit)
Preferred Stock, Value, Issued
Common Stock, Value, Issued
Shares to be issued
Additional paid-in capital
Accumulated deficit
Total Stockholders' Equity (Deficit)
Total Liabilities and Stockholders’ Equity (Deficit)
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Revenue
Total Revenue
Cost of Revenue
Total Cost of Revenue
Gross Profit
Operating Expenses
General and administrative
Advertising and promotion
Clinical trial fees
Corporate filing fees
Equipment leases
Legal and professional fees
Public relations
Repairs and maintenance
Rent
Research and development
Salaries and wages
Utilities
Depreciation and amortization
Total Operating Expenses
Income (Loss) from Operations
Other Income (Expense)
Interest income
Interest expense – related party
Total Other Income (Expense)
Net Income (Loss) Before provision for Income Taxes
Provision for Income Taxes
NET INCOME (LOSS)
Net Income (Loss) Per Share: Basic
Net Income (Loss) Per Share: Diluted
Weighted Average Number of Shares Outstanding: Basic
Weighted Average Number of Shares Outstanding: Diluted
Beginning balance, value
Beginning balance, shares
Cancellation of shares via court order
Cancellation of shares via court order, shares
Shares to be issued for subscriptions – common stock
Shares to be issued for subscriptions - common stock, shares
Net loss
Ending balance, value
Ending balance, shares
Statement of Cash Flows [Abstract]
Cash Flows From Operating Activities:
Net Loss
Adjustments to reconcile net loss to net cash used in operations
Depreciation and amortization
Amortization of right of use asset - operating
Amortization of right-of-use asset - financing
Changes in operating assets and liabilities:
Accounts receivable
Receivable on sale of inventory asset
Prepaid expenses
Inventory
Accounts payable
Accrued interest – line of credit
Deferred revenue
Lease liability - operating
Net Cash Used for Operating Activities
Cash Flows From Investing Activities:
Purchase of furniture & equipment
Loans to clinics
Purchase of intangible assets
Net Used for Investing Activities
Cash Flows From Financing Activities:
Payments made on lease liability - finance
Proceeds from sale of common stock
Line of credit
Net Cash Provided by Financing Activities
Net Increase in Cash
Cash at Beginning of Year
Cash at End of Period
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activities:
Shares to be issued for investment in non-consolidated business entity
Cancellation of shares
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BUSINESS
GOING CONCERN
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Credit Loss [Abstract]
ACCOUNTS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES
Inventory Disclosure [Abstract]
INVENTORY
Property, Plant, and Equipment [Abstract]
FIXED ASSETS, NET
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]
ACQUISITION OF NEW BUSINESS
Investments, All Other Investments [Abstract]
INVESTMENT IN NON-CONSOLIDATED BUSINESS ENTITY
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Loans To Clinics
LOANS TO CLINICS
Leases
LEASES
Equity [Abstract]
STOCKHOLDERS’ EQUITY
Segment Reporting [Abstract]
SEGMENT REPORTING
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation
Use of Estimates
Principles of Consolidation
Cash and Cash Equivalents
Advertising and Promotion Costs
Revenue Recognition
Costs of Revenues
Income Taxes and Valuation Allowance
Financial Instruments
Related Parties
Commitments and Contingencies
Earnings (loss) per share
Inventory
Investments
Leases
Loss Contingencies
Fixed Assets
Long-lived Assets
Segment Reporting
Stock-Based Compensation
Recently Issued Accounting Pronouncements
Schedule of revenue recognition
Schedule of costs of revenues
Schedule of inventory
Schedule of fixed assets
Schedule of right-of-use assets and lease liabilities
Schedule of future payments of lease liabilities
Schedule of segment of assets
Schedule of segment reporting
DisclosureTable [Table]
DisclosureLineitem [Line Items]
Preferred stock voting rights description
Shares issued for compensation, shares
Revenues
Net income (loss)
Accumulated deficit
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Percentage of revenue
Concentration risk, percentage
Property, Plant, and Equipment [Table]
Property, Plant, and Equipment [Line Items]
Cost of revenue
Potentially dilutive common shares
Dividend percentage
Estimated useful lives
Depreciation
Share-based compensation
Allowance for credit losses
Credit loss expense
Credit loss expense
Inventory, Current [Table]
Inventory [Line Items]
Total Inventory
Property and equipment, gross
Less: Accumulated depreciation
Total Fixed Assets, Net
Business Combination [Table]
Business Combination [Line Items]
Membership interest owned
Acquisition value
Business acquisition, inventory acquired
Business acquisition, trademark acquired
Business acquisition, shares issued
Account receivable, noncurrent
Proceeds from sale of business
Stock issued for acquisition, shares
Ownership interest (as a percent)
Dividend income
Line of credit maximum borrowing capacity
Line of credit interest rate
Proceeds from line of credit
Repayment of line of credit
Line of credit amount outstanding
Interest expense
Accrued interest
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Loan receivable
Interest income
Proceeds from note receivable
Right-of-use assets obtained in exchange for new lease liabilities, operating lease
Right-of-use assets obtained in exchange for new lease liabilities, finance lease
Weighted-average remaining lease term, operating lease
Weighted-average remaining lease term, finance lease
Weighted average discount rate, operating lease
Weighted average discount rate, finance lease
Right-of-use assets, operating lease
Right-of-use assets, finance lease
Less: amortization, operating lease
Less: amortization, finance lease
Lease assets, net operating lease
Lease assets, net, finance lease
Lease liabilities, current operating lease
Lease liabilities, current finance lease
Lease liabilities, long-term operating lease
Lease liabilities, long-term finance lease
Total lease obligation operating lease
Total lease obligation finance lease
2026 operating lease
2026 finance lease
2027 operating lease
2027 finance lease
2028 operating lease
2028 finance lease
2029 operating lease
2029 finance lease
Thereafter operating lease
Thereafter finance lease
Payments due operating lease
Payments due finance lease
Less interest operating lease
Less interest finance lease
Total operating lease
Total finance lease
Leases remaining terms
Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]
Subsidiary, Sale of Stock [Line Items]
Common stock par value
Proceeds from issuance of common stock
Offering costs
Stock issued new, shares
Number of shares retired
Preferred stock par value
Shares granted during period, shares
Segment Reporting [Table]
Segment Reporting [Line Items]
Total Assets
Segment Revenue
Total Segment Revenue
Cost of goods sold
Gross Profit
General and administrative
Segment Operating Expenses
Segment Profit (Loss)
Number of operating segment
Number of reportable segment
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Retired shares
Shares issued
Shares outstanding
Special 2022 Series A Preferred Stock [Member]
Sales Of Supplements [Member]
Medical Procedures [Member]
Sales Of Biologics [Member]
Shipping And Delivery [Member]
Services [Member]
Supplements [Member]
Procedures [Member]
Biologics [Member]
Special 2022 Series A Preferred [Member]
Shares To Be Issued [Member]
Monica Sher [Member]
Richard Edwards [Member]
Kalpesh Barot [Member]
Evan Thomas [Member]
Total Revenue [Member]
Cost Of Supplements [Member]
Cost For Administration Of Medical Procedures [Member]
Cost Of Biologics [Member]
Cost Of Revenue [Member]
Total Cost Of Revenue [Member]
Cement Factory, LLC [Member]
Biologic Products [Member]
Biolete, LLC [Member]
Inventory [Member]
Biolete Website [Member]
Cement Factory Nutrition [Member]
CEO Credit Line [Member]
Start Up Loan [Member]
Greater At lanta Integrative Pediatirics [Member]
Regulation A Filing [Member]
Adia Med Assets [Member]
Adia Labs Assets [Member]
Unallocated Corporate Assets [Member]
Adia Labs [Member]
Adia Med [Member]
Sales Of Biologics Net Of Discounts And Refunds [Member]
Coombs [Member]
Lotus [Member]
Assets, Current
Assets, Noncurrent
Liabilities, Current
Liabilities, Noncurrent
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Interest Expense, Nonoperating
Nonoperating Income (Expense)
Income Tax Expense (Benefit)
Shares, Outstanding
Depreciation, Depletion and Amortization
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Inventories and Other Operating Assets
Increase (Decrease) in Prepaid Expense
Increase (Decrease) in Coal Inventories
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Deferred Revenue
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Property, Plant, and Equipment
Payments for Advance to Affiliate
Payments to Acquire Intangible Assets
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Finance Lease, Principal Payments
Proceeds from Long-Term Lines of Credit
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Inventory, Policy [Policy Text Block]
Lessee, Leases [Policy Text Block]
Accounts Receivable, Credit Loss Expense (Reversal)
Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization
Investment Income, Interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Finance Lease, Liability, Undiscounted Excess Amount
General and Administrative Expense